These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 30275094)
1. Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus. Cressey TR; Harrison L; Achalapong J; Kanjanavikai P; Patamasingh Na Ayudhaya O; Liampongsabuddhi P; Siriwachirachai T; Putiyanun C; Suriyachai P; Tierney C; Salvadori N; Chinwong D; Decker L; Tawon Y; Murphy TV; Ngo-Giang-Huong N; Siberry GK; Jourdain G; Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275094 [TBL] [Abstract][Full Text] [Related]
2. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H; N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice. Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596 [TBL] [Abstract][Full Text] [Related]
4. Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy. Bukkems VE; Smolders EJ; Jourdain G; Burger DM; Colbers AP; Cressey TR; J Clin Pharmacol; 2021 Mar; 61(3):388-393. PubMed ID: 32960984 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV. Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771 [TBL] [Abstract][Full Text] [Related]
6. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate. Chang HL; Wen WH; Lee CN; Chiu YE; Liu CJ; Chang MH; Lin LH; Chen HL J Viral Hepat; 2022 Feb; 29(2):107-114. PubMed ID: 34724288 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads. Lin Y; Liu Y; Ding G; Touqui L; Wang W; Xu N; Liu K; Zhang L; Chen D; Wu Y; Bai G Sci Rep; 2018 Oct; 8(1):15514. PubMed ID: 30341345 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Chen HL; Lee CN; Chang CH; Ni YH; Shyu MK; Chen SM; Hu JJ; Lin HH; Zhao LL; Mu SC; Lai MW; Lee CL; Lin HM; Tsai MS; Hsu JJ; Chen DS; Chan KA; Chang MH; ; Hepatology; 2015 Aug; 62(2):375-86. PubMed ID: 25851052 [TBL] [Abstract][Full Text] [Related]
9. Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate. Wen WH; Chen HL; Shih TT; Wu JF; Ni YH; Lee CN; Zhao LL; Lai MW; Mu SC; Tung YC; Hsu HY; Chang MH; J Hepatol; 2020 Jun; 72(6):1082-1087. PubMed ID: 32044401 [TBL] [Abstract][Full Text] [Related]
10. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region. Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022 [TBL] [Abstract][Full Text] [Related]
11. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis. Yang Q; Zhong Z; Yang Y; Ma Y; Flomo KT Gastroenterol Hepatol; 2020 Dec; 43(10):640-648. PubMed ID: 32948358 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200 [TBL] [Abstract][Full Text] [Related]
14. Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis. Lee YS; Lee HS; Kim JH; Chang SW; Hyun MH; Bak H; Kim S; Lee MJ; Lee CU; Jung YK; Seo YS; Yim HJ; Yeon JE; Um SH; Byun KS Korean J Intern Med; 2021 Jan; 36(1):76-85. PubMed ID: 31878771 [TBL] [Abstract][Full Text] [Related]
15. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Wang M; Bian Q; Zhu Y; Pang Q; Chang L; Li R; Tiongson BC; Zhang H; Pan CQ Aliment Pharmacol Ther; 2019 Jan; 49(2):211-217. PubMed ID: 30506691 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: A meta-analysis. Song J; Yang F; Wang S; Tikande S; Deng Y; Tang W; Cao G J Viral Hepat; 2019 Mar; 26(3):397-406. PubMed ID: 30417469 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load. Li B; Liu Z; Liu X; Liu D; Duan M; Gu Y; Liu Q; Ma Q; Wei Y; Wang Y Hepatol Int; 2021 Oct; 15(5):1103-1108. PubMed ID: 34312798 [TBL] [Abstract][Full Text] [Related]
18. The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B. Suoh M; Tamori A; Amano-Teranishi Y; Nakai T; Enomoto M; Kawasaki Y; Kioka K; Kawada N Intern Med; 2020; 59(2):205-210. PubMed ID: 31941870 [TBL] [Abstract][Full Text] [Related]
19. Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study. Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Kim K; Kitrinos KM; Subramanian GM; McHutchison JG; Yee LJ; Elkhashab M; Berg T; Sporea I; Yurdaydin C; Husa P; Jablkowski MS; Gane E J Hepatol; 2017 Jan; 66(1):11-18. PubMed ID: 27545497 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Efficacy and Safety of Tenofovir Disoproxil Fumarate in Intercepting Mother-to-Child Transmission of Hepatitis B Virus. Han D; Du J; Wang W; Wang C Acta Med Okayama; 2024 Apr; 78(2):107-113. PubMed ID: 38688828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]